Biomarin Pharmaceutical (BMRN) Q4 2025 Earnings

27OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.28
0.22
0.73
1.23

Details

Expected EPS
-0.280081
Actual EPS
-0.16
Surprise EPS
0.12
Surprise Percent
+42.87%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.16 per share for Q4 2025.

0 Comments

Share your thoughts